» Articles » PMID: 20506003

Features of Papillary Thyroid Microcarcinoma in the Presence and Absence of Lymphocytic Thyroiditis

Overview
Journal Endocr Pathol
Specialties Endocrinology
Pathology
Date 2010 May 28
PMID 20506003
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

It is known that the prevalence of lymphocytic thyroiditis (LT) is higher in patients with papillary thyroid carcinoma (PTC), that gender influences this association, and that certain features of PTC occur more frequently in patients who also have LT. These relationships have not been studied in patients with papillary thyroid microcarcinomas (PTMC), however. Therefore, we performed a study to compare the clinical and pathological features of patients with PTMC who did and did not have LT. We collected the 323 consecutive patients following excision of PTMC diagnosed as papillary carcinoma on preoperative needle aspiration cytology. We analyzed the demographic, serologic, and pathologic data of those cases with categorization into four groups based on presence of LT and neck lymph node metastasis. In all PTMC, the presence of LT did not influence the frequency of lymph node metastasis (27 of 105 [25.7%] vs. 48 of 218 [22.0%]). Among the patients with metastatic PTMC, LT was noted significantly more often in female than male patients (95.2% vs. 79.8%). In metastatic PTMC, multifocality and bilaterality was more frequent in with LT than without LT (44.4% vs. 29.2%; 29.6% vs. 14.6%). Both the presence of serum thyroglobulin antibody (TgAb; p = 0.016) and serum microsomal antibody (p = 0.013) were highly correlated with the presence of LT. Twenty-seven of 105 patients (25.7%) with PTMC with LT had nodal metastasis. Co-existing LT was noted predominantly in women, influenced more often multifocality and bilaterality of tumors, and higher frequency of metastasis to lateral compartment lymph nodes.

Citing Articles

The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.

Zhang H, Tian L, Wang X, Shi X Front Endocrinol (Lausanne). 2024; 15:1349041.

PMID: 38476675 PMC: 10927769. DOI: 10.3389/fendo.2024.1349041.


Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside.

Valsecchi V, Betoni F, Ward L, Cunha L Rev Endocr Metab Disord. 2023; 25(1):5-17.

PMID: 37889392 DOI: 10.1007/s11154-023-09846-w.


Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.

Yang Y, Liu J, Shi X, Wang M Cancer Control. 2023; 30:10732748231199647.

PMID: 37643366 PMC: 10467246. DOI: 10.1177/10732748231199647.


Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.

Tang Q, Pan W, Peng L PLoS One. 2022; 17(6):e0269995.

PMID: 35709179 PMC: 9202927. DOI: 10.1371/journal.pone.0269995.


Hashimoto's Thyroiditis: A "Double-Edged Sword" in Thyroid Carcinoma.

Xu J, Ding K, Mu L, Huang J, Ye F, Peng Y Front Endocrinol (Lausanne). 2022; 13:801925.

PMID: 35282434 PMC: 8907134. DOI: 10.3389/fendo.2022.801925.


References
1.
Baloch Z, Carayon P, Conte-Devolx B, Demers L, Feldt-Rasmussen U, Henry J . Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003; 13(1):3-126. DOI: 10.1089/105072503321086962. View

2.
Singh B, Shaha A, Trivedi H, Carew J, Poluri A, Shah J . Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery. 1999; 126(6):1070-6; discussion 1076-7. DOI: 10.1067/msy.2099.101431. View

3.
Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K . The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab. 1995; 80(12):3421-4. DOI: 10.1210/jcem.80.12.8530576. View

4.
Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio M, Busutti L . Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab. 2006; 91(6):2171-8. DOI: 10.1210/jc.2005-2372. View

5.
DAILEY M, Lindsay S, SKAHEN R . Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955; 70(2):291-7. DOI: 10.1001/archsurg.1955.01270080137023. View